Short Interest in PharmaCielo Ltd. (OTCMKTS:PCLOF) Grows By 30.7%

PharmaCielo Ltd. (OTCMKTS:PCLOF) was the target of a significant growth in short interest in April. As of April 15th, there was short interest totaling 85,990 shares, a growth of 30.7% from the March 31st total of 65,776 shares. Based on an average daily trading volume, of 113,875 shares, the days-to-cover ratio is currently 0.8 days.

PharmaCielo Price Performance

Shares of OTCMKTS:PCLOF traded up $0.01 during midday trading on Friday, hitting $0.04. The stock had a trading volume of 40,333 shares, compared to its average volume of 68,961. PharmaCielo has a 12 month low of $0.00 and a 12 month high of $0.12. The business’s 50-day simple moving average is $0.04 and its 200-day simple moving average is $0.04.

About PharmaCielo

PharmaCielo (OTCMKTS:PCLOF) is a Colombia-based, vertically integrated cannabinoid extraction and manufacturing company that develops pharmaceutical-grade active ingredients for the global medical cannabis market. The company specializes in the cultivation, extraction, purification and isolation of cannabinoids, producing a range of high-purity oils, distillates and isolates that serve as the active pharmaceutical ingredients (APIs) in end-use formulations. PharmaCielo’s product portfolio is designed to meet Good Manufacturing Practices (GMP) standards, enabling partnerships with pharmaceutical firms and wellness brands seeking compliant, consistently standardized cannabinoid inputs.

Since commencing operations, PharmaCielo has established a state-of-the-art extraction facility in Colombia, leveraging the country’s favorable agronomic conditions and regulatory framework for medicinal cannabis cultivation.